drug

Vorinostat Oral Capsule Group 2

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Virginia Commonwealth University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
HDAC Inhibitor Augmentation to Clozapine
NCT03263533Early Phase 1Withdrawn

KOLs & investigators

1
Javier Gonzalez-Maeso, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Virginia Commonwealth University
company
trial
HDAC Inhibitor Augmentation to Clozapine
EARLY_PHASE1
trial
indication
Schizophrenia
indication
Schizophrenia
indication
KOL
Javier Gonzalez-Maeso, PhD
KOL score —
person